Skip to content

Evaluation of drug Dexmedetomidine as part of anaesthetic regimen during conduct of brain tumor surgery.

Evaluation of Dexmedetomidine as anaesthetic adjunct to Propofol during Bispectral Index guided anaesthesia for cerebello-pontine angle surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007667
Enrollment
48
Registered
2017-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cerebello-pontine angle tumour patients

Interventions

Intervention1: Dexmedetomidine
Propofol
Fentanyl: Intraoperative continuous infusion of Dexmedetomidine (0.5 micgm/kg/hr) + Fentanyl (0.5 micgm/kg/hr) + Propofol (via Target Controlled Infusion - Schnider model - titrated to maintain Bispec
Fentanyl: Intraoperative continuous infusion of Fentanyl (0.5 micgm/kg/hr) + Propofol (via Target Controlled Infusion - Schnider model - titrated to maintain Bispectral Index between 40 - 60)

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Cerebello-pontine angle surgeries with cranial nerve monitoring.

Exclusion criteria

Exclusion criteria: 1) Patients with evidence of sino-atrial nodal or atrio-ventricular nodal bradyarrhythmia on ECG, baseline heart rate 2) Patients with known history of hypertension and being treated with anti-hypertensive drugs. 3) Patients on tricyclic antidepressant, clonidine, monoamine oxidase-inhibitor therapy. 4) Patients with evidence of impaired hepatic/renal function according to past history or preoperative biochemistry parameters. 5) Need for intraoperative inotrope/vasopressor drug. 6) Allergy to egg/propofol 7) Absence of cranial nerve monitoring during surgery

Design outcomes

Primary

MeasureTime frame
Quantification of anaesthetic and analgesic sparing effect of dexmedetomidine.Timepoint: End of anaesthesia.

Secondary

MeasureTime frame
1) Recovery from anaesthesia based on time to opening eyes, time to following commands and time to extubation after anaesthetic withdrawal. 2) Evaluate the effect propofol alone and propofol-dexmedetomidine combination on acid base status. 3) Observe the incidence of adverse haemodynamic events. 4) Observe the effect of these two anaesthetic techniques on postoperative sedation, nausea and vomiting, shivering and pain scores. Timepoint: End of anaesthesia.

Countries

India

Contacts

Public ContactKR Madhusudan Reddy

National Insitute of Mental Health and Neuro Sciences

rosesrred90@gmail.com8197781240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026